Nisreen Moghrabi-Al
Riyadh, 11211, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women.
Journal: International journal of molecular sciences
Published: January 31, 2024
MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers.
Journal: International journal of molecular sciences
Published: April 11, 2023
MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated BRCA1.
Journal: Oncology letters
Published: January 17, 2022
Eugenol modulates genomic methylation and inactivates breast cancer-associated fibroblasts through E2F1-dependent downregulation of DNMT1/DNMT3A.
Journal: Molecular carcinogenesis
Published: April 06, 2021
Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
Journal: Oncology reports
Published: August 25, 2019
Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters.
Journal: Clinical epigenetics
Published: April 05, 2018
Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
Journal: International journal of oncology
Published: January 28, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026